药品验证对新生儿重症监护病房处方错误的影响. 随机和受控研究研究
M D Canales-Siguero1,2, C García-Muñoz1, J M Caro-Teller1
1Department of Pharmacy, 12 de Octubre University Hospital, Madrid, Spain.
Frontiers in pediatrics
|April 19, 2024
概括
临床药剂师验证显著减少了新生儿重症监护室 (NICU) 的电子处方错误. 这种制药护理模式通过尽量减少药物错误到达新生儿,提高了患者的安全.
科学领域:
- 新生儿重症监护室新生儿重症监护室
- 临床药房 临床药房 临床药房
- 药物的安全性 药物的安全性
背景情况:
- 电子处方系统在新生儿重症监护室 (NICU) 中至关重要,但可能容易出错.
- 确保易受伤害的新生儿的药物安全需要强大的错误检测和纠正机制.
研究的目的:
- 为了比较电子处方错误的发生率,当处方被临床药剂师验证时与未经验证时相比.
- 评估药品验证对新生儿重症监护病房药物安全性的影响.
主要方法:
- 一项前性随机对照研究在第三级医院的NICU中进行.
- 患者被分为对照组和干预组,干预组进行药物验证.
- 该研究包括干预前后阶段,以评估验证过程的影响.
主要成果:
- 经过药剂师验证的干预组发现的处方错误明显较少 (129对270;p < 0.001).
- 到达患者的处方错误从对照组的40%急剧减少到干预组的1.6%.
- 在干预前和干预后期间,错误的处方行从3.4%降至1.5% (p = 0.005).
结论:
- 电子处方的药品验证显著减少了处方工具中的错误.
- 实施临床药剂师验证过程显著减少了到达患者的处方错误数量,提高了新生儿安全.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


